Recent insights regarding the molecular basis of myeloproliferative neoplasms

Mi Ae Jang, Chul Won Choi

Research output: Contribution to journalArticle

Abstract

Myeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal disorders characterized by the overproduction of mature blood cells that have an increased risk of thrombosis and progression to acute myeloid leukemia. Next-gen-eration sequencing studies have provided key insights regarding the molecular mechanisms of MPNs. MPN driver mutations in genes associated with the JAK-STAT pathway include JAK2 V617F, JAK2 exon 12 mutations and mutations in MPL, CALR, and CSF3R. Cooperating driver genes are also frequently detected and also mutated in other myeloid neoplasms; these driver genes are involved in epigenetic methylation, messenger RNA splicing, transcription regulation, and signal transduction. In addition, other genetic factors such as germline predisposition, order of mutation acquisition, and variant allele frequency also influence disease initiation and progression. This review summarizes the current understanding of the genetic basis of MPN, and demonstrates how molecular pathophysiology can improve both our understanding of MPN heterogeneity and clinical practice.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalKorean Journal of Internal Medicine
Volume35
Issue number1
DOIs
Publication statusPublished - 2020 Jan 1

Fingerprint

Neoplasms
Mutation
Genes
RNA Splicing
Gene Frequency
Acute Myeloid Leukemia
Epigenomics
Methylation
Disease Progression
Exons
Signal Transduction
Blood Cells
Thrombosis

Keywords

  • Essential
  • Mutation
  • Polycythemia vera
  • Primary myelofibrosis
  • Thrombocythemia

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Recent insights regarding the molecular basis of myeloproliferative neoplasms. / Jang, Mi Ae; Choi, Chul Won.

In: Korean Journal of Internal Medicine, Vol. 35, No. 1, 01.01.2020, p. 1-11.

Research output: Contribution to journalArticle

@article{03a5c06c442b419dbe33fbb6f29f898c,
title = "Recent insights regarding the molecular basis of myeloproliferative neoplasms",
abstract = "Myeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal disorders characterized by the overproduction of mature blood cells that have an increased risk of thrombosis and progression to acute myeloid leukemia. Next-gen-eration sequencing studies have provided key insights regarding the molecular mechanisms of MPNs. MPN driver mutations in genes associated with the JAK-STAT pathway include JAK2 V617F, JAK2 exon 12 mutations and mutations in MPL, CALR, and CSF3R. Cooperating driver genes are also frequently detected and also mutated in other myeloid neoplasms; these driver genes are involved in epigenetic methylation, messenger RNA splicing, transcription regulation, and signal transduction. In addition, other genetic factors such as germline predisposition, order of mutation acquisition, and variant allele frequency also influence disease initiation and progression. This review summarizes the current understanding of the genetic basis of MPN, and demonstrates how molecular pathophysiology can improve both our understanding of MPN heterogeneity and clinical practice.",
keywords = "Essential, Mutation, Polycythemia vera, Primary myelofibrosis, Thrombocythemia",
author = "Jang, {Mi Ae} and Choi, {Chul Won}",
year = "2020",
month = "1",
day = "1",
doi = "10.3904/kjim.2019.317",
language = "English",
volume = "35",
pages = "1--11",
journal = "Korean Journal of Internal Medicine",
issn = "0494-4712",
publisher = "Korean Association of Internal Medicine",
number = "1",

}

TY - JOUR

T1 - Recent insights regarding the molecular basis of myeloproliferative neoplasms

AU - Jang, Mi Ae

AU - Choi, Chul Won

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Myeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal disorders characterized by the overproduction of mature blood cells that have an increased risk of thrombosis and progression to acute myeloid leukemia. Next-gen-eration sequencing studies have provided key insights regarding the molecular mechanisms of MPNs. MPN driver mutations in genes associated with the JAK-STAT pathway include JAK2 V617F, JAK2 exon 12 mutations and mutations in MPL, CALR, and CSF3R. Cooperating driver genes are also frequently detected and also mutated in other myeloid neoplasms; these driver genes are involved in epigenetic methylation, messenger RNA splicing, transcription regulation, and signal transduction. In addition, other genetic factors such as germline predisposition, order of mutation acquisition, and variant allele frequency also influence disease initiation and progression. This review summarizes the current understanding of the genetic basis of MPN, and demonstrates how molecular pathophysiology can improve both our understanding of MPN heterogeneity and clinical practice.

AB - Myeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal disorders characterized by the overproduction of mature blood cells that have an increased risk of thrombosis and progression to acute myeloid leukemia. Next-gen-eration sequencing studies have provided key insights regarding the molecular mechanisms of MPNs. MPN driver mutations in genes associated with the JAK-STAT pathway include JAK2 V617F, JAK2 exon 12 mutations and mutations in MPL, CALR, and CSF3R. Cooperating driver genes are also frequently detected and also mutated in other myeloid neoplasms; these driver genes are involved in epigenetic methylation, messenger RNA splicing, transcription regulation, and signal transduction. In addition, other genetic factors such as germline predisposition, order of mutation acquisition, and variant allele frequency also influence disease initiation and progression. This review summarizes the current understanding of the genetic basis of MPN, and demonstrates how molecular pathophysiology can improve both our understanding of MPN heterogeneity and clinical practice.

KW - Essential

KW - Mutation

KW - Polycythemia vera

KW - Primary myelofibrosis

KW - Thrombocythemia

UR - http://www.scopus.com/inward/record.url?scp=85077896598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077896598&partnerID=8YFLogxK

U2 - 10.3904/kjim.2019.317

DO - 10.3904/kjim.2019.317

M3 - Article

C2 - 31778606

AN - SCOPUS:85077896598

VL - 35

SP - 1

EP - 11

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

SN - 0494-4712

IS - 1

ER -